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INTRODUCTION
Critical thinking about diagnostics and 
monitoring of cerebral vasospasm must 
take into account few basic facts. The 
first important thing is to distinguish two 
anatomically different structures: cerebral 
blood vessels and living tissue of the brain. 
Size and shape of cerebral arteries are the 
main point in radiological (digital sub-
traction angiography and other) morpho-
logical methods of investigation in brain 
heamodynamics. Changes in living brain 
tissue during brain ischemia can be detect-
ed by biochemical (cerebral microdialysis) 
or physical methods (magnetic resonance 
imaging, electrophysiology). Therefore, 
considering symptomatic cerebral vasos-
pasm, at least two different methods of di-
agnostics should be applied: morphologi-
cal one for detecting the size and shapeof 
cerebral arteries, and biological or physical 
one for detecting ischemic brain tissue.
The second important fact in diagnostics 
of cerebral vasospasm is the definition of 
vasospasm itself. There must be clear clini-
cal scenario (subarachnoid hemorrhage) 
and clear distinction to other similar pa-
thology (reversible cerebral vasoconstric-
tion syndrome). 
These facts make an important logical 
frame in diagnostics of  cerebral vasos-
pasm.   Clinically significant and symp-
tomatic vasospasm develops in 20-30% of 
patients with aneurysmal subarachnoid 
hemorrhage (SAH). It is a major contribu-
tor to higer mortality and permanent dis-
ability rate. However, vascular imaging 
methods show incidence of cerebral vasos-
pasm in up to 40-70% of SAH patients, but 
not all are symptomatic (1). 
Symptomatic vasospasm is defined as the 
presence of neurological worsening in-
cluding focal deficit, decline in level of 
consciousness, and motor paresis; no other 
identifiable cause (intracranial disorder 
and systemic complication) of neurologi-
cal worsening; and confirmation of vasos-
pasm by medical examinations (1-3). 
Delayed cerebral ischemia (DCI) is a 
broader term that refers to the delayed 
development of a focal neurological defi-
cit, decline in level of consciousness and/
or cerebral infarction. It includes a number 
of clinical entities, one being symptomatic 
vasospasm. Exact mechanisms responsible 
for development of vasospasm and delayed 
cerebral ischemia are still unknown. Pos-
sible candidates are recognized as factors 
in pathophysiology of vasospasm (ni-
trous oxide, endothelin, oxyhaemoglobin, 
thrombin, serotonin, thromboxane A2, 
noradrenaline, sphingosine-1-phosphate), 
but further research is needed. Some pa-
tients develop delayed ischemic neurologi-
cal deficit without angiographyc cerebral 
vasospasm. Recent studies suggest that 
vasospasm isn't the only contributor for 
developing delayed cerebral ischemia and 
that pathophysiology is probably multifac-
torial.
Diagnosing symptomatic vasospasm is 
difficult, especially in sedated or coma-
tose patients. It is made by exclusion of 
all other causes of neurological deficit or 
conciousness level deterioration. The ideal 
diagnostic method for detecting cerebral 
vasospasm should be fast and easy to per-
form bedside, easily reproducible, with a 
high specificity and sensitivity, without 
any adverse effects or complications, and 
cost-effective.  In this paper we will focus 
on available methods of diagnosing and 
monitoring of cerebral vasospasm.
METHODS OF MONITORING CER-
EBRAL VASOSPASM
Digital subtraction angiography
Digital subtraction angiography (DSA) of 
cerebral arteries is the gold standard of di-
agnosis of cerebral vasospasm. It is highly 
sensitive and specific in detecting cerebral 
vasospasm. Nevertheless, it is an invasive 
procedure, requires substantial amount 
of resources, patient needs to be sedated 
and it is time consuming. DSA is associ-
ated with <1% risk of complications, major 
ones being dissection of artery or intraar-
terial thrombosis. One study reported a 
2.6% risk of a second hemorrhage from 
a ruptured aneurysm during DSA per-
formed within 6 h after initial SAH. Dur-
ing DSA procedure, the distal intracarotid 
pressure rises during injection of contrast 
medium, which could potentially lead to 
re-rupture of an aneurysm. DSA can be 
utilized to apply vasodilatating agent se-
lectively to the affected artery or provide 
access to endovascular intervention such 
as balloon angioplasty. Major limitation is 
difficulty in inspecting distal parts of cer-
ebral arterial tree (2). 
CT Angiography                         
                                                                                            
CT Angiography (CTA) is considered to 
be less invasive than DSA, highly sensitive 
and specific method with the procedure 
lasting significantly less, and is associated 
with a lower risk of re-rupture (4). Com-
pared to DSA it is accurate in detecting 
cerebral vasospasm in proximal, higher-lu-
men arteries but is less accurate in mild to 
moderate vasospasm in distal arteries (5). 
Contrast media containing iodine used 
either for DSA or CTA can have direct 
spastic effect by hyperosmolarity and also 
by stimulation of vasomotor mediators, 
promoting vasoconstriction (6). Quality 
of CTA imaging is affected by the patients’ 
movement or artefacts after coiling or clip-
ping of an aneurysm, superposition of vas-
cular structures other than those in focus 
of examination. Both CTA and DSA have 
been shown to overestimate the severity of 
vasospasm.
Low-dose perfusion computed tomog-
raphy                                                                                 
Low-dose perfusion computed tomogra-
phy (CTP) is non invasive method to diag-
nose cerebral vasospasm with high speci-
ficity and sensitivity. A decrease in cerebral 
blood flow (CBF) and prolongation of 
mean transit time (MTT) on baseline CTP 
performed within 3 days following SAH 
have been found to be >90% specific for 
the development of vasospasm (7).  Re-
ports also show that CTP can be a method 
to predict delayed cerebral ischemia and 
can give prognostic information in SAH 
patients (8). 
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Transcranial Doppler ultrasonography
Transcranial Doppler ultrasonography 
(TCD) is an ultrasound method of detec-
tion of high speed blood flow through cer-
ebral arteries. This method is non-invasive, 
inexpensive, fast, easily reproducible and 
repeatable during the course of treatment. 
It has no serious side effects and can be 
done real-time along patients bedside. It 
depends on the experience of the person 
performing the procedure. Another disad-
vantage of TCD is its inability to detect va-
sospasm in smaller blood vessels, in vessels 
positioned deeper in the brain tissue and 
those covered with thicker bone, such as 
posterior circulation arteries. Even in ex-
amining middle cerebral artery up to 20% 
of patients have inadequate ultrasound 
window through temporal bone (9).  TCD 
is based on a principle that a decrease in a 
diameter of a vessel will cause an increase 
in a blood flow velocity, but there are many 
other factors influencing cerebral blood 
flow and mean velocity flow. These factors 
include age, sex, hypercarbia, hematocrit 
level, mean arterial pressure and pregnan-
cy (10). 
Meta-analysis testing reliability of TCD 
to predict proximal middle cerebral ar-
tery spasm, found prediction rate of 97%, 
but sensitivity of this method of only 67% 
(11). Results on sensitivity and specificity 
in evaluating anterior cerebral artery and 
posterior cerebral artery are poorer. Com-
bining various ratios such as Lindegaard 
ratio (middle cerebral artery flow veloc-
ity/internal carotid artery flow velocity) or 
spasm index (TCD velocity/hemispheric 
CBF) signifficantly improved sensitivity 
of TCD. There are no relevant data that 
TCD-guided therapy and decision-making 
based on TCD findings influence outcome 
of patients with anurysmal SAH.  Despite 
all limitations, Neurocritical Care Society 
in its recommendations still names TCD 
as a tool for monitoring and detection of 
large artery vasospasm  with  variable  sen-
sitivity. Recommended thresholds of mean 
blood flow velocities are <120 cm/s for 
absence and >200 cm/s and/or MCA/ICA 
ratio >6  for  presence  of vasospasm (12). 
Magnetic resonance imaging
Perfusion-weighted magnetic resonance 
imaging (MRI) can detect small areas of 
early ischemic injury and locate the va-
sospasm. With this method it is possible 
to calculate cerebral blood volume and 
by combining it with mean transit time, 
patients who may benefit from hemody-
namic augmentation therapy can be differ-
entiated (13). Diagnostic procedures such 
as positron emission tomography (PET), 
xenon-enhanced CT (Xe-CT), and single-
photon emission computed tomography 
(SPECT) can detect areas of reduced me-
tabolism and higher oxygen demand, but 
just like MRI, can not pin-point the causa-
tive vessel.
   
Brain tissue oxygen monitoring
Brain tissue oxygen monitoring is a di-
agnostic method in which the catheter 
is inserted in the penumbra (potentially 
salvageable brain tissue surrounding is-
chemic core). It continuously collects data 
such as brain tissue oxygenation, partial 
pressure of oxygen and carbon dioxide, pH 
and temperature. Studies show correlation 
between tissue oxygen pressure (PtiO2) 
and vasospasm. Loss of autoregulation in 
the affected parts of the brain can be seen 
using this type of monitoring, by correlat-
ing the PtiO2 to the MAP (14,15). 
Based on information collected by the 
catheter, haemodynamic support is used to 
elevate cerebral blood flow and/or oxygen 
delivery, improve carbon-dioxide washout, 
and sedation is sometimes used to reduce 
metabolic rate of oxygen. It is possible to 
determine the effect of any therapeutic in-
tervention in real time. Randomized con-
trolled studies about influence of guiding 
therapy according to PtiO2 values on out-
come of SAH patients are lacking. Major 
limitation of this method is invasiveness 
and correct positioning of probe.
Cerebral microdialysis
Cerebral microdialysis is an invasive di-
agnostic procedure that can evaluate focal 
levels of various metabolic substrates (such 
as glucose, glutamate, lactate, but there is 
a variety of other ones that can be meas-
ured). Rise of anaerobic metabolite levels 
is specific for cerebral ischaemia and can 
even be used as a prognostic tool in de-
layed ischaemic injury (16). 
Jugular venous bulb oximetry
Jugular venous bulb oximetry can provide 
data about the global cerebral blood flow, 
cerebral oxygen demand, oxygen delivery, 
lactate production and pH mostly from ip-
silateral brain hemisphere. Samples can be 
taken intermitently or oxygen saturation 
in the jugular venous bulb can be continu-
ously monitored. Very brief and transient 
episodes of cerebral desaturation, even for 
as long as 15 minute, can be a sole predic-
tion factor of poorer neurological outcome 
(17). It can also be used to monitor the ef-
fect of therapeutic interventions (18). In-
vestigation on small group of patients show 
that increase in cerebral oxygen extraction 
is predictive for symptomatic vasospasm 
(19). It is an invasive method with risk of 
developing thrombus at the catheter tip or 
other complications related to the proce-
dure of placing the catheter (haematoma 
formation, bacteriemia and infection, arte-
rial puncture). Monitored parameters are 
from pooled blood, so it is possible that 
normal surrounding areas may mask a lo-
cal change, thus reducing the sensitivity of 
jugular bulb venous oximetry.
Near infrared spectroscopy                      
                                                                                                           
Near infrared spectroscopy (NIRS) is non-
invasive diagnostic method used to evalu-
ate tissue oxygenation by emitting near-in-
frared light through the skull and into the 
cerebral cortex near the surface. Reflected 
light is then converted to the electrical sig-
nal similar to that of the pulse oxymetry, 
giving quantitative information about oxy-
gen saturation. It can be used continuously. 
Measurement of cortical oxygen saturation 
can give information on regional cortical 
blood flow, and can also be used to assess 
autoregulation and vasospasm. One study 
on a small group of patients concluded 
that NIRS is a comparable method with CT 
perfusion imaging and may serve as a non-
invasive, safe, bedside monitoring tool for 
regional brain oxygenation and indirectly 
cerebral blood flow. Another recent report 
found cortical oxygen saturation decrease 
to be predictive for vasospasm of middle 
cerebral artery (20,21). There are several 
other papers confirming these findings, 
but larger prospective studies are needed 
in order to validate this method before it 
becomes a standard practice of care for 
SAH patients.
Other neuromonitoring devices      
                                                                                                   
There are numerous haemodynamic mon-
itoring devices and methods used today, 
but as the technology advances, many 
more are being developed to be more ef-
ficient, safer, faster and easier to use. One 
of the new devices currently is NAS-1000, 
the haemodynamics neuromonitor which 
detects neurovascular pulsatility wave-
forms. It is noninvasive and apropriate for 
continuous use. Low frequency acoustic 
signal is being detected and converted to 
a waveform pattern that, depending on 
the amplitude and frequency, can detect 
neurovascular pathology. In one prospec-
tive, non-randomised study that included 
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athletes suffering from concussion, NAS-
1000 detected concussion with a sensitiv-
ity of 86.1%, and specificity of 91%, and 
these numbers tell us of it's potential in 
predicting this clinical entity (22). Since 
the FDA approval is still pending, there are 
studies to be made to prove its sensitivity 
and specificity to different conditions that 
affect cerebral haemodynamics. Optoa-
coustic imaging is promising developing 
technology that combines anatomic and 
functional imaging in real time and can 
successfully detect cerebral hemodynamic 
changes associated with brain function 
(23). 
To conclude, there are many neuromoni-
toring devices and techniques used today, 
giving valuable information mainly about 
cerebral haemodynamics. These meth-
ods are being constantly improved and 
new approaches to monitoring CBF, CBV, 
glucose utilization and cerebral oxygena-
tion are being investigated and put into 
everyday practice in neurosurgical critical 
care units. Even though the use of cerebral 
haemodynamics monitoring is impera-
tive in the neurosurgical ICU, the best ap-
proach to assess perfusion and metabolism 
of the brain seems to be the combination 
of different methods, intermittently or 
continuously collecting information. It is 
important to recognize indications and 
familiarize with old as well as new meth-
ods to provide best possible treatment and 
to be able to employ individually tailored 
therapy for each patient.
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